EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY-NC-ND 4.0

Prospective, Randomized, Multi-centric, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of KSM-66 Ashwagandha (Withania somnifera) in Adults Experiencing High Stress and/or Anxiety: Clinical Study Protocol

Deepak Langade, Jaising Salve, Prasanthi Sampara

D Y Patil Journal of Health Sciences · 2026-04 · 14 (2) · 119-122

DOI: 10.4103/dypj.dypj_33_25 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift D Y Patil Journal of Health Sciences, online erschienen am 14.08.2026. Verfasst von Deepak Langade und 2 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Modern life often leads to stress, manifesting physical symptoms like fatigue and headaches, as well as emotional effects such as anxiety and mood changes. Ashwagandha ( Withania somnifera ), a key medicinal plant in Indian Ayurveda, is renowned for its anti-stress and vitality-enhancing properties. This study aims to assess the efficacy and safety of Ashwagandha root extract in adults experiencing high stress and anxiety. Materials and Methods: This study is a prospective, randomized, multi-national, multi-center, double-blind, placebo-controlled trial designed to assess the safety and tolerability of Ashwagandha ( Withania somnifera ) root extract (ARE) in adults across different populations. The primary focus of the overall trial is on stress and anxiety reduction; this segment specifically investigates the safety and tolerability of ARE in an adult population. A total of 1000 subjects with anxiety and stress disorders were enrolled in the study.

Conclusion

This study will provide compelling evidence that KSM-66 Ashwagandha root extract is a safe and well-tolerated intervention for reducing stress and managing anxiety in healthy adults.

Zitieren

APA

Langade, D., Salve, J., & Sampara, P. (2026). Prospective, Randomized, Multi-centric, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of KSM-66 Ashwagandha (Withania somnifera) in Adults Experiencing High Stress and/or Anxiety: Clinical Study Protocol. D Y Patil Journal of Health Sciences, 14(2), 119-122. https://doi.org/10.4103/dypj.dypj_33_25

Vancouver

Langade D, Salve J, Sampara P. Prospective, Randomized, Multi-centric, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of KSM-66 Ashwagandha (Withania somnifera) in Adults Experiencing High Stress and/or Anxiety: Clinical Study Protocol. D Y Patil Journal of Health Sciences. 2026;14(2):119-122. doi:10.4103/dypj.dypj_33_25

BibTeX
@article{Langade2026,
  author = {Langade, Deepak and Salve, Jaising and Sampara, Prasanthi},
  title = {Prospective, Randomized, Multi-centric, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of KSM-66 Ashwagandha (Withania somnifera) in Adults Experiencing High Stress and/or Anxiety: Clinical Study Protocol},
  journal = {D Y Patil Journal of Health Sciences},
  year = {2026},
  volume = {14},
  number = {2},
  pages = {119--122},
  doi = {10.4103/dypj.dypj_33_25}
}
Kostenlos starten →